Does race, income predict prostate cancer outcome?
A patient's socioeconomic status (income, martial status and race) has absolutely no impact on his outcome following curative radiation therapy for the treatment of prostate cancer, according to a new study from Henry Ford Hospital in Detroit. "This study offers an extremely important message for all patients with prostate cancer who receive radiation therapy," says Benjamin Movsas, M.D., senior study author and chair of the Department of Radiation Oncology at Henry Ford Hospital in Detroit. "Despite the fact that there was a large difference in income based on race, none of the socioeconomic status factors predicted for outcome. All patients did equally well, based on the known prognostic factors."
The study is being presented Nov. 4 at the 51st Annual American Society for Radiation Oncology (ASTRO) meeting in Chicago. It is unique in that nearly 50 percent of patients in the analysis are African American.
Previous studies on socioeconomic status and cancer outcomes done by other groups have had conflicting results, according to study lead author Farzan Siddiqui, M.D., Ph.D., with the Department of Radiation Oncology at Henry Ford Hospital.
One study, for example, suggested that African Americans with breast or colon cancer do much worse than white patients because they receive care at hospitals with less expertise. Another showed that men with prostate cancer who are married have better outcomes than those who are unmarried or without a partner. And yet other studies suggested that hospitals with large minority patient populations have higher mortality for cancer.
"Henry Ford Hospital treats a large number of African American patients and has excellent cancer outcomes, so we really began to question results from many of these prior studies," says Dr. Siddiqui. "One of the issues is that many of these studies include a relatively small percentage of African American patients. In comparison, almost half of our study group was African American, which allowed us to do a more accurate assessment of how socioeconomic status affects prostate cancer outcomes."
The study included 788 Henry Ford Hospital patients with localized prostate cancer who were treated with external beam radiation therapy. Among those in the study, 48.5 percent were African American with a median household income $36,917, and 46 percent were white with a median household income of $60,190. The patients' ages ranged from 44 to 90.
While there was a large difference in median household income among African Americans and whites, none of the socioeconomic factors examined predicted for patient outcome. Only known disease risk factors determined overall survival or biochemical (PSA) control rates.
"Our results suggest if patients are properly cared for and managed that their race, income and marital status should not affect their outcome," says Dr. Siddiqui.
Source: Henry Ford Health System
Articles on the same topic
- Time between treatment and PSA recurrence predicts death from prostate cancerWed, 4 Nov 2009, 20:09:57 UTC
- Radiation therapy after lumpectomy for breast cancer can be safely reduced to 4 weeksWed, 4 Nov 2009, 18:11:33 UTC
- 3-week course of breast radiation may be as effective as conventional 5- to 7-week course for early breast cancersWed, 4 Nov 2009, 18:11:32 UTC
- Cancer patients want honesty, compassion from their oncologistWed, 4 Nov 2009, 17:31:15 UTC
- Shorter radiation course stops cancer growth in high-risk prostate cancer patientsTue, 3 Nov 2009, 18:26:31 UTC
- Shorter radiation course as effective as standard therapy for prostate cancer recurrenceTue, 3 Nov 2009, 18:26:29 UTC
- Radiation therapy technique successfully treats pain in patients with advanced cancerTue, 3 Nov 2009, 16:08:59 UTC
- PET imaging before radiation not ideal for determining boost radiation dosesTue, 3 Nov 2009, 15:46:33 UTC
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patientsMon, 2 Nov 2009, 18:24:29 UTC
- Proton therapy is well-tolerated in prostate cancer patientsMon, 2 Nov 2009, 17:59:49 UTC
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsMon, 2 Nov 2009, 17:44:13 UTC
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsMon, 2 Nov 2009, 17:44:11 UTC
- Stereotactic radiotherapy offers noninvasive, effective treatment for lung cancer patientsMon, 2 Nov 2009, 17:44:10 UTC
- Adding proton therapy 'boost' to X-ray radiation therapy reduces prostate cancer recurrencesMon, 2 Nov 2009, 17:39:33 UTC
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancerMon, 2 Nov 2009, 17:15:37 UTC
- Preventative brain radiation for lung cancer patients: Benefits and risksMon, 2 Nov 2009, 16:51:41 UTC
- Undetectable PSA after radiation is possible and predicts good patient outcomesMon, 2 Nov 2009, 16:33:07 UTC
- Additional, specialized radiation not necessary for some women after mastectomyMon, 2 Nov 2009, 16:33:05 UTC
- Real benefits vs. risks of preventative brain radiation for nonsmall cell lung cancer patientsMon, 2 Nov 2009, 16:33:04 UTC
- Radiation after surgery reduces chance of melanoma returningMon, 2 Nov 2009, 16:33:03 UTC
- Short-term hormone therapy added to radiation increases survival for medium-risk, but not low-risk, prostate cancer patientsMon, 2 Nov 2009, 16:33:00 UTC
Other sources
- Irradiated cancers stay downfrom Science AlertThu, 5 Nov 2009, 8:14:23 UTC
- Radiation therapy after lumpectomy for breast cancer can be safely reduced to 4 weeksfrom PhysorgWed, 4 Nov 2009, 21:28:05 UTC
- Cancer patients want honesty, compassion from their oncologistfrom PhysorgWed, 4 Nov 2009, 19:14:06 UTC
- Radiation therapy technique successfully treats pain in patients with advanced cancerfrom Science BlogTue, 3 Nov 2009, 21:07:19 UTC
- PET imaging before radiation not ideal for determining boost radiation dosesfrom PhysorgTue, 3 Nov 2009, 19:56:11 UTC
- Radiation Therapy Technique Successfully Treats Pain In Patients With Advanced Cancerfrom Science DailyTue, 3 Nov 2009, 17:21:13 UTC
- Radiation therapy technique successfully treats pain in patients with advanced cancerfrom PhysorgTue, 3 Nov 2009, 16:35:53 UTC
- Additional, specialized radiation not necessary for some women after mastectomyfrom PhysorgTue, 3 Nov 2009, 7:56:07 UTC
- Adding proton therapy 'boost' to X-ray radiation therapy reduces prostate cancer recurrencesfrom PhysorgTue, 3 Nov 2009, 4:56:07 UTC
- Proton Therapy Is Well-tolerated In Prostate Cancer Patientsfrom Science DailyTue, 3 Nov 2009, 4:14:07 UTC
- Stereotactic radiotherapy stops lung cancer from growing in frail patientsfrom PhysorgTue, 3 Nov 2009, 3:28:16 UTC
- Preventative brain radiation for lung cancer patients: Benefits and risksfrom PhysorgTue, 3 Nov 2009, 3:28:14 UTC
- Proton therapy is well-tolerated in prostate cancer patientsfrom PhysorgTue, 3 Nov 2009, 1:14:18 UTC
- Undetectable PSA after radiation is possible and predicts good patient outcomesfrom PhysorgTue, 3 Nov 2009, 0:07:19 UTC
- Radiation after surgery reduces chance of melanoma returningfrom PhysorgMon, 2 Nov 2009, 22:56:16 UTC
- Obesity significantly increases side effects of stereotactic body radiation therapy in lung cancer patientsfrom PhysorgMon, 2 Nov 2009, 21:49:15 UTC
- Preventative brain radiation for lung cancer patients: Benefits and risksfrom Science BlogMon, 2 Nov 2009, 18:49:09 UTC
- Short-term hormone therapy and intermediate dose radiation increases survivial for early stage prostate cancerfrom PhysorgMon, 2 Nov 2009, 17:42:15 UTC
- Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment for Frail Patients with Early-stage Lung Cancerfrom Newswise - ScinewsMon, 2 Nov 2009, 17:42:07 UTC
- Undetectable PSA After Radiation Is Possible And Predicts Good Patient Outcomesfrom Science DailyMon, 2 Nov 2009, 17:21:30 UTC
- Radiation After Surgery Reduces Chance Of Melanoma Returningfrom Science DailyMon, 2 Nov 2009, 16:28:58 UTC